131 related articles for article (PubMed ID: 23359768)
1. Antiproliferative effects of zinc-citrate compound on hormone refractory prostate cancer.
Hong SH; Choi YS; Cho HJ; Lee JY; Kim JC; Hwang TK; Kim SW
Chin J Cancer Res; 2012 Jun; 24(2):124-9. PubMed ID: 23359768
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis of bladder cancer cells by zinc-citrate compound.
Hong SH; Choi YS; Cho HJ; Lee JY; Hwang TK; Kim SW
Korean J Urol; 2012 Nov; 53(11):800-6. PubMed ID: 23185674
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R)) on human epithelial ovarian cancer cell line, OVCAR-3.
Bae SN; Lee YS; Kim MY; Kim JD; Park LO
Gynecol Oncol; 2006 Oct; 103(1):127-36. PubMed ID: 16624386
[TBL] [Abstract][Full Text] [Related]
4. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.
Cardoso HJ; Vaz CV; Correia S; Figueira MI; Marques R; Maia CJ; Socorro S
Prostate; 2015 Jun; 75(9):923-35. PubMed ID: 25786656
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Mol Cancer Ther; 2004 Feb; 3(2):169-78. PubMed ID: 14985457
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effect of zinc-citrate compound on choriocarcinoma cell lines.
Bae SN; Kim J; Lee YS; Kim JD; Kim MY; Park LO
Placenta; 2007 Jan; 28(1):22-30. PubMed ID: 16503348
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
Huang YW; Wang LS; Chang HL; Ye W; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2006; 26(3A):1925-33. PubMed ID: 16827126
[TBL] [Abstract][Full Text] [Related]
9. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
10. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
[TBL] [Abstract][Full Text] [Related]
11. Pseudolaric acid B induces apoptosis via proteasome-mediated Bcl-2 degradation in hormone-refractory prostate cancer DU145 cells.
Zhao D; Lin F; Wu X; Zhao Q; Zhao B; Lin P; Zhang Y; Yu X
Toxicol In Vitro; 2012 Jun; 26(4):595-602. PubMed ID: 22388098
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 4-hydroxynonenal-induced p53-mediated apoptosis in prostate cancer cells LNCaP and DU145.
Cao ZG; Xu X; Xue YM; Zhao SL
Contemp Oncol (Pozn); 2014; 18(1):22-8. PubMed ID: 24876817
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues.
Singh KK; Desouki MM; Franklin RB; Costello LC
Mol Cancer; 2006 Apr; 5():14. PubMed ID: 16595004
[TBL] [Abstract][Full Text] [Related]
14. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
[TBL] [Abstract][Full Text] [Related]
15. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
16. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor.
Tam CW; Cheng AS; Ma RY; Yao KM; Shiu SY
Endocrinology; 2006 Nov; 147(11):5023-33. PubMed ID: 16873542
[TBL] [Abstract][Full Text] [Related]
19. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells.
Chang HK; Shin MS; Yang HY; Lee JW; Kim YS; Lee MH; Kim J; Kim KH; Kim CJ
Biol Pharm Bull; 2006 Aug; 29(8):1597-602. PubMed ID: 16880611
[TBL] [Abstract][Full Text] [Related]
20. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
